These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 21475911)

  • 1. Fascin overexpression is regulated by the transactivation of the promoter but not by its hypomethylation in esophageal squamous cell carcinoma.
    Hou J; Guo ZY; Xie JJ; Li EM; Xu LY
    Mol Med Rep; 2009; 2(5):843-9. PubMed ID: 21475911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
    Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D
    BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells.
    Xie JJ; Xu LY; Zhang HH; Cai WJ; Mai RQ; Xie YM; Yang ZM; Niu YD; Shen ZY; Li EM
    Biochem Biophys Res Commun; 2005 Nov; 337(1):355-62. PubMed ID: 16185662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
    Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
    BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
    Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
    Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.
    Fatima S; Chui CH; Tang WK; Hui KS; Au HW; Li WY; Wong MM; Cheung F; Tsao SW; Lam KY; Beh PS; Wong J; Law S; Srivastava G; Ho KP; Chan AS; Tang JC
    Int J Mol Med; 2006 Jan; 17(1):159-70. PubMed ID: 16328025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.
    Kim MS; Yamashita K; Chae YK; Tokumaru Y; Chang X; Zahurak M; Osada M; Park HL; Chuang A; Califano JA; Sidransky D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6658-65. PubMed ID: 18006766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
    Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
    Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
    Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.